Jiangsu Aidea Pharmaceutical Co Ltd (688488) — Free Cash Flow Generation Index

Latest as of September 2025: 0.49x

Jiangsu Aidea Pharmaceutical Co Ltd (688488) has a Free Cash Flow Generation Index of 0.49x as of September 2025. Free cash flow of CN¥1.76 Million represents 0% of operating cash flow (CN¥3.56 Million). Explore Jiangsu Aidea Pharmaceutical Co Ltd (688488) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

0.49x
Free Cash Flow / Operating CF

Free Cash Flow

CN¥1.76 Million
CNY

Operating Cash Flow

CN¥3.56 Million
CNY

Capital Expenditures

CN¥1.81 Million
CNY

Jiangsu Aidea Pharmaceutical Co Ltd Free Cash Flow Generation Index (2016–2025)

Historical FCF Generation Index trend for Jiangsu Aidea Pharmaceutical Co Ltd across 4 annual periods. For the full cash flow conversion analysis, see Jiangsu Aidea Pharmaceutical Co Ltd cash conversion from operations.

Annual Free Cash Flow Generation for Jiangsu Aidea Pharmaceutical Co Ltd (2016–2025)

Year-by-year Free Cash Flow Generation Index for Jiangsu Aidea Pharmaceutical Co Ltd. Check 688488 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.

Year FCG Index Free Cash Flow (CNY) Operating CF Capital Expenditures YoY Change
2025 -1.72x CN¥-30.30 Million CN¥17.63 Million CN¥47.93 Million ▼ -802.6%
2020 0.24x CN¥13.74 Million CN¥56.17 Million CN¥42.43 Million ▼ -39.4%
2019 0.40x CN¥22.70 Million CN¥56.20 Million CN¥33.50 Million ▲ +131.8%
2016 -1.27x CN¥-39.72 Million CN¥31.29 Million CN¥71.01 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).